46.52
price up icon5.15%   2.28
after-market Dopo l'orario di chiusura: 47.00 0.48 +1.03%
loading

Terns Pharmaceuticals Inc Azioni (TERN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Costs And Expenses
1.22%
27.72
27.38 27.43 25.95 24.94
Operating Income/Loss
1.22%
-27.72
-27.38 -27.43 -25.95 -24.94
Nonoperating Income/Loss
6.77%
3.127
3.354 3.607 4.19 3.056
Income/Loss From Continuing Operations Before Tax
2.33%
-24.59
-24.03 -23.82 -21.76 -21.88
Income Tax Expense/Benefit
28.12%
0.046
0.064 0.088 0.04 0.062
Income/Loss From Continuing Operations After Tax
2.25%
-24.64
-24.09 -23.91 -21.80 -21.95
Net Income/Loss
2.25%
-24.64
-24.09 -23.91 -21.80 -21.95
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.14%
91.70
91.58 91.47 3.9396 77.82
Diluted Average Shares
0.14%
91.70
91.58 91.47 3.9396 77.82
Basic Earnings Per Share
3.85%
-0.27
-0.26 -0.26 -0.23 -0.28
Diluted Earnings Per Share
3.85%
-0.27
-0.26 -0.26 -0.23 -0.28
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):